Register for our webinar to learn how to identify sources of contamination and reduce contamination risk.
Overview
Any contamination introduced during the production of biologicals can pose significant potential safety risks for patients. Biopharmaceutical manufacturers must understand the most effective methods for quickly identifying sources of such contamination, particularly when developing cell and gene therapies. By doing so, they can reduce contamination risk and cut down on costly product recalls.
Objective
In this invaluable discussion, Daniel Tatarsky will host a conversation on tracking contaminants in the biomanufacturing process as per European Pharmacopoeia and USP. Firstly, our experts will provide an overview of the contamination risks, and then they will provide an in-depth review of the latest mycoplasma testing techniques. They will cover both rapid and culture methods as well as adventitious virus testing using molecular and virology methods.
Agenda
- Contamination risks during biologicals production
- Mycoplasma testing using rapid and culture methods
- Adventitious virus testing using molecular and virology methods
- Q&A
Target Audience
This webinar is aimed at experts involved in manufacturing for biopharmaceutical companies.
For further information, please contact:
Aurelia Resines
Global Marketing Head
t: +41 22 739 91 11